Reported Earlier, Traws Pharma Ratutrelvir Demonstrates Broad-Spectrum Activity Against SARS-CoV-2 Without Ritonavir Enabling Treatment Of PAXLOVID-Ineligible Patients And Prevention Of Viral Rebound
Author: Benzinga Newsdesk | October 23, 2025 02:14am